obesity
Decrements in the thrombin activatable fibrinolysis inhibitor (TAFI) levels in association with orlistat treatment in obesity.
Decrements in the <span class="gene" id="16959692-0-18-61">thrombin activatable fibrinolysis inhibitor</span> (<span class="gene" id="16959692-0-63-67">TAFI</span>) levels in association with orlistat treatment in <span class="disease" id="16959692-0-118-125">obesity</span>.